The ICS Neurourology Promotion Committee have started writing a guideline document for sacral neuromodulation (SNM). SNM has been approved by the FDA since 1990 for refractory voiding dysfunction. Indications have expanded since this time but there are still no guidelines for implanters. The committee requires input from those who routinely implant and we would be grateful for anyone who conducts SNM to complete the survey.
The survey takes 20 minutes to complete and the feedback from this survey will become the core of the guidelines. Please complete the survey by 26th May 2016.
Complete the SNM Survey